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Abstract: Background & Aims: Hepatic stellate cells (HSC) 
transdifferentiation into collagen-producing myofibroblasts is a key 
event in hepatic fibrogenesis, but the transcriptional network that 
controls the acquisition of the activated phenotype is still poorly 
understood. In this study, we explored whether the nuclear receptor 
Chicken Ovalbumin Upstream Promoter-Transcription Factor II (COUP-TFII) 
is involved in HSC activation and in the multifunctional role of these 
cells during the response to liver injury.  
Methods: COUP-TFII expression was evaluated in normal and cirrhotic 
livers by immunohistochemistry and western blot. The role of COUP-TFII in 
HSC was assessed by gain and loss of function transfection experiments 
and by generation of mice with COUP-TFII deletion in HSC. Molecular 
changes were determined by gene expression microarray and RT-qPCR. 
Results: We showed that COUP-TFII is highly expressed in human fibrotic 
liver and in mouse models of hepatic injury. COUP-TFII expression rapidly 
increased upon HSC activation and it was associated with the regulation 
of genes involved in cell motility, proliferation and angiogenesis. 
Inactivation of COUP-TFII impairs proliferation and invasiveness in 
activated HSC and COUP-TFII deletion in mice abrogate HSC activation and 
angiogenesis. Finally, co-culture experiments with HSC and liver 
sinusoidal endothelial cells (SEC) showed that COUP-TFII expression in 
HSC influenced SEC migration and tubulogenesis via a hypoxia-independent 
and NF- -dependent mechanism.  
Conclusion: This study elucidates a novel transcriptional pathway in HSC 
that is involved in the acquisition of the proangiogenic phenotype and 
regulates the paracrine signals between HSC and sinusoidal endothelial 
cells during hepatic wound healing.     
 
 
Response to Reviewers: Response to reviewer comment 
Point-by-point reply letter 
Reviewer 1. 
 1. We agree with the reviewer about the significance of the molecular 
mechanisms by which COUP-TFII regulates target genes. Molecular mechanism 
of COUP-TFII actions is complex, this receptor can recognize different 
response direct repeats (DR) separated by a different number of 
nucleotides competing for occupancy of the binding sites with other 
nuclear receptors such as PPARs, RARs, VDR, and GR. In addition COUP-TFII 
is able to activate transcription through protein-protein interaction 
with DNA-bound factors. Some proangiogenic gene such as VEGF-C have a 
COUP-TFII response element in their promoters (DR-1) (Yamazaki T et al. 
Gene to Cell 2009). On the contrary most cytokines modulated by COUP-TFII 
have not a specific COUP-TFII response element in their promoters. We 
hypnotized that COUP-TFII can modulate these genes by an indirect 
transactivation as accessory regulator. We have demonstrated in ChIP 
assay that antibodies raised against human COUP-TFII immuniprecipitated 
DNA fragment corresponding to different NF-kB response elements. This 
data have been added in the result section and in Supplemental Figure S11     
2. We thank the review to indicate this area of investigation. Notch 
is an important regulator of angiogenesis by its target genes Hes and Hey 
transcription factors.  Notch ligands in the liver control the 
inflammatory response by repressing NF-kB (Oakley F et al. J Biol Chem 
2003, Shen Z, et al. Am J Pathol 2016). Notch is also an important 
regulator of COUP-TFII expression during vasculogenesis (You LR, et al 
Nature 2005). Here we showed that the Notch ligand Jag-1 strongly 
repressed COUP-TFII expression and transcriptional activity in HSC and 
this effect was mediated by Hey-1. We also  pointed out that Hey1 
silencing restored COUP-TFII expression in Jag-1 treated HSC. In addition 
we investigated the effect of COUP-TFII on Notch target genes  showing 
that COUP-TFII repressed Hes-1 and Hey1 expression in activate HSC. These 
data are described in an new paragraph of the Results section and in 
Supplemental Figure S12.     
3. We agree that CCl4 metabolism and hepatocyte toxicity are a central 
point to validate our result. We tested serum ALT, hepatic content of 
Malondialdehyde and CYP2E expression. The levels of these parameters were 
similar both in control and COUP-TFII KO mice. We added this results in 
Supplemental Figure S9.  We are grateful to the reviewer for this 
suggestion. 
  Reviewer 2.  
1. We agree with the reviewer that Lrat-Cre mice is a better model of 
stellate cells specific knock-out but it is not available. Anyway GFAP-
Cre is still commonly used for stellate cells specific deletion 
(Mochizuki A, et al. J Immunol 2014). In order to confirm HSC specific 
targeting we performed a detailed analysis of COUP-TFII expression is 
isolated different cell populations from control and CCl4 treated mice. 
We found that COUP-TFII expression was absent in COUP-TFIIfl/fl-GFAP Cre+ 
, on the contrary both Hepatocytes and Sinusoidal endothelial cells 
expressed COUP-TFII at a lower level than activated stellate cells and it 
remained unchanged in all groups with or without CCl4 treatment. We were 
not able to demonstrate COUP-TFII expression in Kupffer cells. These data 
are added in Supplementary Figure S8.  
 
2. As requested by the reviewer we added and addition panel 
(Supplementary Figure S1) where confocal microscopy images confirm that 
COUP-TFII is highly expressed in α-SMA positive cells located in the 
fibrotic septa, and that CD68 positive cells do not express COUP-TFII.  
 
3. To address this point we evaluated the effect of COUP-TFII expression 
on two “traditional” markers of activated HSC, α-SMA and Col1α2. These 
genes were induced in human HSC by transfection of COUP-TFIIwt expression 
plasmid whereas transfection of the  dominant negative construct 
significantly inhibited α-SMA and Col1α2 steady state levels. These data 
are included in Supplementary Figure S6 and added in the Result section.  
4. Laser Doppler flowmetry that has been shown a suitable method for 
estimation of hepatic microcirculation was performed to confirm the 
proangiogenic role of COUP-TFII.  We demonstrated that hepatic 
microcirculation was significantly reduced in CCl4-treated COUP-
TFIIfl/fl-GFAP Cre+ mice compared to COUP-TFIIfl/fl-GFAP Cre-. These data 
were described in the Results section and in the Supplementary Figure 
S10.  
5. We agree with the reviewer about the increased scientific impact of 
the paper by including a second fibrosis model, so we introduced 
experiments in bile duct ligated mice. Similar to CCL4 treated mice, BDL-
COUP-TFIIfl/fl-GFAP Cre+ mice have a significant reduction of fibrosis 
compared to BDL-COUP-TFIIfl/fl-GFAP Cre- animals. These experiments are 
included in Figure 5.  
 
Minor. We realized that details in Figure 5 are difficult to appreciate 
due to the necessarily low size of the images in a crowded panel. 
However, making figures in colour will further reduce the contrast, 
making even more difficult to see positive staining. Therefore, greyscale 
images were processed by background subtraction algorithm and contrast-
stretched to improve clarity. All images were processed uniformly. We 
hope that positive signal is now easier to see. 
  
 
 
Dear Dr. Vijay Shah 
 
Thank you very much for your letter of June 27
th 
 2016 that included the useful comments of the 
reviewers about the revision of our paper entitled "The orphan nuclear receptor COUP-TFII 
coordinates hypoxia-independent proangiogenic responses in hepatic stellate cells" JHEPAT-D-16-
01100. 
In the present version of the manuscript we addressed all the points raised by Reviewers as specified in 
the enclosed point-by point reply letter.  
In particular, 
 
1. We included data showing that COUP-TFII receptor is modulated by Notch signaling. Notch is 
an important regulator of angiogenesis by its target genes Hes and Hey transcription factors.  
We showed that Notch ligand Jag-1 strongly repressed COUP-TFII expression and 
transcriptional activity and this effect was mediated by Hey-1. We pointed out that Hey1 
silencing  restored COUP-TFII expression in Jag-1 treated HSC. In addition we investigated the 
effect of COUP-TFII on Notch target genes  showing that COUP-TFII repressed Hes-1 and 
Hey1 expression in activate HSC. These data are very intriguing in the context of  previous 
observation indicating that Notch activation in HSC inhibits NF-kB (Oakley F et al. J Biol 
Chem 2003) 
2. We addressed the reviewer 1 request by performing  ChIP assay to better define the molecular 
mechanism by which COUP-TFII regulate target genes. In particular we demonstrate that 
COUP-TFII binds the NF-kB response elements on IL-8 promoter suggesting that this orphan 
receptor might function as positive accessory regulator through protein-protein interaction with 
DNA-bound factors.   
3. We reinforced the evidence that COUP-TFII is express in α-SMA expressing cells in the septa 
Cover Letter
of cirrhotic liver by a more specific confocal microscopy images.  
4. In order to confirm the proangiogenic role of COUP-TFII we performed Laser Doppler 
flowmetry that has been shown a suitable method for estimation of hepatic microcirculation 
(Hung KC et al. Oncology letters 2013). We demonstrated that hepatic microcirculation was 
significantly reduced in CCl4-treated COUP-TFII
fl/fl
-GFAP Cre
+
 mice compared to COUP-
TFIIfl/fl-GFAP Cre-. 
5. A second fibrosis model was included. We introduced experiments in mice after bile duct 
ligation. Similar to CCL4 treated mice, BDL-ligated  COUP-TFIIfl/fl-GFAP Cre+ mice have a 
significant reduction of fibrosis compared to control mice.  
6. Several  figures have been added in supplemental material  according reviewers' requests and 
variations in the text have been underlined. 
Please find attached the point to point replay to the specific questions raised by the reviewers. 
Given the new experimental evidences added, we hope that our paper in now suitable for publication in 
Journal of Hepatology. 
Sincerely 
Andrea Galli, MD, PhD 
Gastroenterology Research Unit 
Department of Experimental and Clinical Biochemical Sciences 
University of Florence 
Viale Pieraccini 6 
50139-Florence ITALY 
Tel:  +39(055)275811 
FAX  +39(055)2758411 
a.galli@dfc.unifi.it 
Point-by-point reply letter 
Reviewer 1. 
 
1. We agree with the reviewer about the significance of the molecular mechanisms by which 
COUP-TFII regulates target genes. Molecular mechanism of COUP-TFII actions is complex, 
this receptor can recognize different response direct repeats (DR) separated by a different 
number of nucleotides competing for occupancy of the binding sites with other nuclear 
receptors such as PPARs, RARs, VDR, and GR. In addition COUP-TFII is able to activate 
transcription through protein-protein interaction with DNA-bound factors. Some proangiogenic 
gene such as VEGF-C have a COUP-TFII response element in their promoters (DR-1) 
(Yamazaki T et al. Gene to Cell 2009). On the contrary most cytokines modulated by COUP-
TFII have not a specific COUP-TFII response element in their promoters. We hypnotized that 
COUP-TFII can modulate these genes by an indirect transactivation as accessory regulator. We 
have demonstrated in ChIP assay that antibodies raised against human COUP-TFII 
immuniprecipitated DNA fragment corresponding to different NF-kB response elements. This 
data have been added in the result section and in Supplemental Figure S11     
2. We thank the review to indicate this area of investigation. Notch is an important regulator of 
angiogenesis by its target genes Hes and Hey transcription factors.  Notch ligands in the liver 
control the inflammatory response by repressing NF-kB (Oakley F et al. J Biol Chem 2003, 
Shen Z, et al. Am J Pathol 2016). Notch is also an important regulator of COUP-TFII 
expression during vasculogenesis (You LR, et al Nature 2005). Here we showed that the Notch 
ligand Jag-1 strongly repressed COUP-TFII expression and transcriptional activity in HSC and 
this effect was mediated by Hey-1. We also  pointed out that Hey1 silencing restored COUP-
TFII expression in Jag-1 treated HSC. In addition we investigated the effect of COUP-TFII on 
Notch target genes  showing that COUP-TFII repressed Hes-1 and Hey1 expression in activate 
HSC. These data are described in an new paragraph of the Results section and in Supplemental 
Figure S12.     
3. We agree that CCl4 metabolism and hepatocyte toxicity are a central point to validate our result. 
We tested serum ALT, hepatic content of Malondialdehyde and CYP2E expression. The levels 
of these parameters were similar both in control and COUP-TFII KO mice. We added this 
results in Supplemental Figure S9.  We are grateful to the reviewer for this suggestion. 
  Reviewer 2.  
1. We agree with the reviewer that Lrat-Cre mice is a better model of stellate cells specific knock-out 
but it is not available. Anyway GFAP-Cre is still commonly used for stellate cells specific deletion 
(Mochizuki A, et al. J Immunol 2014). In order to confirm HSC specific targeting we performed a 
detailed analysis of COUP-TFII expression is isolated different cell populations from control and CCl4 
treated mice. We found that COUP-TFII expression was absent in COUP-TFIIfl/fl-GFAP Cre+ , on the 
contrary both Hepatocytes and Sinusoidal endothelial cells expressed COUP-TFII at a lower level than 
activated stellate cells and it remained unchanged in all groups with or without CCl4 treatment. We 
were not able to demonstrate COUP-TFII expression in Kupffer cells. These data are added in 
Supplementary Figure S8.  
 
2. As requested by the reviewer we added and addition panel (Supplementary Figure S1) where 
confocal microscopy images confirm that COUP-TFII is highly expressed in α-SMA positive cells 
located in the fibrotic septa, and that CD68 positive cells do not express COUP-TFII.  
 
3. To address this point we evaluated the effect of COUP-TFII expression on two “traditional” markers 
of activated HSC, α-SMA and Col1α2. These genes were induced in human HSC by transfection of 
COUP-TFIIwt expression plasmid whereas transfection of the  dominant negative construct 
significantly inhibited α-SMA and Col1α2 steady state levels. These data are included in 
Supplementary Figure S6 and added in the Result section.  
4. Laser Doppler flowmetry that has been shown a suitable method for estimation of hepatic 
microcirculation was performed to confirm the proangiogenic role of COUP-TFII.  We demonstrated 
that hepatic microcirculation was significantly reduced in CCl4-treated COUP-TFIIfl/fl-GFAP Cre+ 
mice compared to COUP-TFIIfl/fl-GFAP Cre-. These data were described in the Results section and in 
the Supplementary Figure S10.  
5. We agree with the reviewer about the increased scientific impact of the paper by including a second 
fibrosis model, so we introduced experiments in bile duct ligated mice. Similar to CCL4 treated mice, 
BDL-COUP-TFIIfl/fl-GFAP Cre+ mice have a significant reduction of fibrosis compared to BDL-
COUP-TFIIfl/fl-GFAP Cre- animals. These experiments are included in Figure 5.  
 
Minor. We realized that details in Figure 5 are difficult to appreciate due to the necessarily low size of 
the images in a crowded panel. However, making figures in colour will further reduce the contrast, 
making even more difficult to see positive staining. Therefore, greyscale images were processed by 
background subtraction algorithm and contrast-stretched to improve clarity. All images were processed 
uniformly. We hope that positive signal is now easier to see. 
  
 
 Point-by-point reply letter 
Reviewer 1. 
 
1. We agree with the reviewer about the significance of the molecular mechanisms by which COUP-TFII 
regulates target genes. Molecular mechanism of COUP-TFII actions is complex, this receptor can recognize 
different response direct repeats (DR) separated by a different number of nucleotides competing for occupancy 
of the binding sites with other nuclear receptors such as PPARs, RARs, VDR, and GR. In addition COUP-TFII is 
able to activate transcription through protein-protein interaction with DNA-bound factors. Some proangiogenic 
gene such as VEGF-C have a COUP-TFII response element in their promoters (DR-1) (Yamazaki T et al. Gene to 
Cell 2009). On the contrary most cytokines modulated by COUP-TFII have not a specific COUP-TFII response 
element in their promoters. We hypnotized that COUP-TFII can modulate these genes by an indirect 
transactivation as accessory regulator. We have demonstrated in ChIP assay that antibodies raised against 
human COUP-TFII immuniprecipitated DNA fragment corresponding to different NF-kB response elements. This 
data have been added in the result section and in Supplemental Figure S11     
2. We thank the review to indicate this area of investigation. Notch is an important regulator of 
angiogenesis by its target genes Hes and Hey transcription factors.  Notch ligands in the liver control the 
inflammatory response by repressing NF-kB (Oakley F et al. J Biol Chem 2003, Shen Z, et al. Am J Pathol 2016). 
Notch is also an important regulator of COUP-TFII expression during vasculogenesis (You LR, et al Nature 2005). 
Here we showed that the Notch ligand Jag-1 strongly repressed COUP-TFII expression and transcriptional 
activity in HSC and this effect was mediated by Hey-1. We also  pointed out that Hey1 silencing restored COUP-
TFII expression in Jag-1 treated HSC. In addition we investigated the effect of COUP-TFII on Notch target genes  
showing that COUP-TFII repressed Hes-1 and Hey1 expression in activate HSC. These data are described in an 
new paragraph of the Results section and in Supplemental Figure S12.     
3. We agree that CCl4 metabolism and hepatocyte toxicity are a central point to validate our result. We 
tested serum ALT, hepatic content of Malondialdehyde and CYP2E expression. The levels of these parameters 
were similar both in control and COUP-TFII KO mice. We added this results in Supplemental Figure S9.  We are 
grateful to the reviewer for this suggestion. 
  Reviewer 2.  
1. We agree with the reviewer that Lrat-Cre mice is a better model of stellate cells specific knock-out but it is 
not available. Anyway GFAP-Cre is still commonly used for stellate cells specific deletion (Mochizuki A, et al. J 
Immunol 2014). In order to confirm HSC specific targeting we performed a detailed analysis of COUP-TFII 
expression is isolated different cell populations from control and CCl4 treated mice. We found that COUP-TFII 
expression was absent in COUP-TFIIfl/fl-GFAP Cre+ , on the contrary both Hepatocytes and Sinusoidal 
endothelial cells expressed COUP-TFII at a lower level than activated stellate cells and it remained unchanged 
in all groups with or without CCl4 treatment. We were not able to demonstrate COUP-TFII expression in 
Kupffer cells. These data are added in Supplementary Figure S8.  
*Detailed Response to Reviewers
 2. As requested by the reviewer we added and addition panel (Supplementary Figure S1) where confocal 
microscopy images confirm that COUP-TFII is highly expressed in α-SMA positive cells located in the fibrotic 
septa, and that CD68 positive cells do not express COUP-TFII.  
 
3. To address this point we evaluated the effect of COUP-TFII expression on two “traditional” markers of 
activated HSC, α-SMA and Col1α2. These genes were induced in human HSC by transfection of COUP-TFIIwt 
expression plasmid whereas transfection of the  dominant negative construct significantly inhibited α-SMA and 
Col1α2 steady state levels. These data are included in Supplementary Figure S6 and added in the Result 
section.  
4. Laser Doppler flowmetry that has been shown a suitable method for estimation of hepatic microcirculation 
was performed to confirm the proangiogenic role of COUP-TFII.  We demonstrated that hepatic 
microcirculation was significantly reduced in CCl4-treated COUP-TFIIfl/fl-GFAP Cre+ mice compared to COUP-
TFIIfl/fl-GFAP Cre-. These data were described in the Results section and in the Supplementary Figure S10.  
5. We agree with the reviewer about the increased scientific impact of the paper by including a second fibrosis 
model, so we introduced experiments in bile duct ligated mice. Similar to CCL4 treated mice, BDL-COUP-
TFIIfl/fl-GFAP Cre+ mice have a significant reduction of fibrosis compared to BDL-COUP-TFIIfl/fl-GFAP Cre- 
animals. These experiments are included in Figure 5.  
 
Minor. We realized that details in Figure 5 are difficult to appreciate due to the necessarily low size of the 
images in a crowded panel. However, making figures in colour will further reduce the contrast, making even 
more difficult to see positive staining. Therefore, greyscale images were processed by background subtraction 
algorithm and contrast-stretched to improve clarity. All images were processed uniformly. We hope that 
positive signal is now easier to see. 
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Transcription factor II; ECM, extracellular matrix; GFAP, glial fibrillary acidic protein; HIF, 
hypoxia-inducible factor; HSC hepatic stellate cells; PPAR, Peroxisome Proliferator-activated 
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siRNA, small interfering RNA; -SMA,  smooth muscle actin; VEGF-C, vascular endothelial 
growth factor C.  
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Abstract 
 
Background & Aims: Hepatic stellate cells (HSC) transdifferentiation into collagen-producing 
myofibroblasts is a key event in hepatic fibrogenesis, but the transcriptional network that controls 
the acquisition of the activated phenotype is still poorly understood. In this study, we explored 
whether the nuclear receptor Chicken Ovalbumin Upstream Promoter-Transcription Factor II 
(COUP-TFII) is involved in HSC activation and in the multifunctional role of these cells during the 
response to liver injury.  
Methods: COUP-TFII expression was evaluated in normal and cirrhotic livers by 
immunohistochemistry and western blot. The role of COUP-TFII in HSC was assessed by gain and 
loss of function transfection experiments and by generation of mice with COUP-TFII deletion in 
HSC. Molecular changes were determined by gene expression microarray and RT-qPCR. 
Results: We showed that COUP-TFII is highly expressed in human fibrotic liver and in mouse 
models of hepatic injury. COUP-TFII expression rapidly increased upon HSC activation and it was 
associated with the regulation of genes involved in cell motility, proliferation and angiogenesis. 
Inactivation of COUP-TFII impairs proliferation and invasiveness in activated HSC and COUP-
TFII deletion in mice abrogate HSC activation and angiogenesis. Finally, co-culture experiments 
with HSC and liver sinusoidal endothelial cells (SEC) showed that COUP-TFII expression in HSC 
influenced SEC migration and tubulogenesis via a hypoxia-independent and NF-B-dependent 
mechanism.  
Conclusion: This study elucidates a novel transcriptional pathway in HSC that is involved in the 
acquisition of the proangiogenic phenotype and regulates the paracrine signals between HSC and 
sinusoidal endothelial cells during hepatic wound healing.  
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Lay Summary: In this study we identified an important regulator of HSC pathobiology. We 
showed that the orphan receptor COUP-TFII is an important player of hepatic neoangiogenesis. 
COUP-TFII expression in HSC controls the cross-talk between HSC and endothelial cells 
coordinating vascular remodeling during liver injury.        
 
Introduction 
 
An exuberant wound healing response to chronic liver injury culminates in excessive and altered 
deposition of extracellular matrix (ECM) components that is temporally and spatially linked with 
vascular remodelling of hepatic sinusoids, angiogenesis and recruitment of inflammatory cells (1). 
Hepatic stellate cells (HSC) play an important role in the physiological homeostasis of ECM in the 
liver and are the precursors of activated myofibroblast-like cells responsible for the development of 
liver fibrosis. Indeed, in healthy liver, HSC are specialized pericytes characterized by cytoplasmic 
lipid droplets rich in retinyl esters and located in the subendothelial space of hepatic sinusoids in 
direct communication with hepatocytes and endothelial cells (2). Following liver injury HSC 
undergo an activation process from the resting-fat storing phenotype towards a myofibroblast-like 
phenotype, characterized by increased cell proliferation, enhanced expression of proinflammatory 
and proangiogenic cytokines and deranged synthesis of ECM components (3).  
Both the initial phase of HSC activation and the persistence of the activated phenotype involve 
subtle variations of regulatory intracellular mechanisms, which are orchestrated by an elaborated 
network of transcription factors coordinating a complex reprogramming of gene expression (4). 
Interestingly, quiescent HSC express adipocytic markers and the transcriptional program required 
for maintaining their fat-storing phenotype has striking similarities with that of adipocyte 
differentiation (5). In particular, the peroxisome proliferator-activated receptor  (PPAR) and liver 
X receptor α (LXRα), the master regulators of adipocyte differentiation (6), are expressed in HSC 
and their expression and activity is reduced during in vivo and in vitro HSC activation (7-8).  
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 6 
Although anti-adipogenic pathways as TNF-α and nectin-Wnt promote HSC activation (9), the 
transcriptional mechanisms linking the loss of adipogenic features with the acquisition of 
profibrogenic and proangiogenic phenotype in HSC remain unclear. 
 
Chicken ovalbumin upstream promoter-transcription factors (COUP-TFs) are members of the 
nuclear receptor superfamily. Since no physiologic ligands have been so far discovered they are 
regarded as “orphan” (10). Three mammalian orthologues have been  identified, COUP-TFI (Nr2f1) 
and COUP-TFII (Arp-1, Nr2f2,) and the more distantly related COUP-TFIII (Nr2f6). These 
transcription factors are involved in several important biological processes, such as organogenesis, 
cell fate determination, and energetic metabolism homeostasis (11). COUP-TFs are generally 
considered to be repressors of transcription for other nuclear hormone receptors but can also 
function as direct positive regulators for many different genes (12).  
COUP-TFI and COUP-TFII show an exceptional homology, suggesting that they may serve 
redundant functions, nonetheless the spatially and temporally different expression in the developing 
embryos and in adult animals indicates that these two receptors are involved in different biological 
processes. COUP-TFII is highly expressed in mesenchymal cells and plays a crucial role in 
mesenchymal-endothelial interaction determining vein identity and angiogenesis during vascular 
development (13-14). Recent evidence have shown that COUP-TFII is also expressed in adipose 
tissue and it represses adipogenesis by antagonizing PPAR thus contributing to the antiadipogenic 
effect of the Wnt pathway (15).  
In reason of this converging information, the present study was designed to determine the role of 
COUP-TFII in hepatic wound healing and HSC biology. We report that COUP-TFII is 
overexpressed in fibrotic liver and it is up-regulated during HSC activation.  Our functional analysis 
reveals that COUP-TFII transcriptional activity in HSC modulates a hypoxia-independent 
proangiogenic program involved in the paracrine crosstalk between HSC and sinusoidal endothelial 
cells (SEC).  
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Methods 
 
Full methods are available in Supplementary material.     
 
Human Tissue 
Normal and cirrhotic liver samples used for histochemical studies were obtained from surgical 
waste sections obtained from patients undergoing liver resection under institutional review board-
approved protocols. In particular, cirrhotic liver tissue (METAVIR 4) was obtained from 11 patients 
with HCV-related cirrhosis undergoing orthotopic liver transplantation. The use of this material is 
conformed to the ethical guidelines of the Declaration of Helsinki and was approved by the Human 
Research Review Committee of the University of Florence.  
 
Conditional COUP-TFII-deficient mice 
To reduce COUP-TFII levels in HSC, COUP-TFII
fl/fl 
mice, described in detail previously (16) were 
crossed with mice expressing Cre ricombinase under control of the gliar fibrillary acidic protein 
(GFAP) promoter (B6.Cg-TgGfap-cre 73.12Mvs/Jmice). Both strains of mice were backcrossed to 
C57BL/6J (Harlan; Monza, Italy) for at least 12 generation. COUP-TFII
fl/fl 
-GFAP Cre
- 
and COUP-
TFII
fl/fl 
-GFAP Cre
+ 
littermates were used for these studies. Experiments were performed in 
accordance with the institutional ethical guidelines of the University of Florence.   
 
DNA vectors and transfection of cultured human HSC  
Quiescent HSC were transfected with reporter and expression plasmids at the density of 6 x 10
5
 
cells/well by TransIT-2020 transfection reagent (Mirus Bio LLC, Medison WI) following the 
manufacturer's instructions. Forty-eight hours after transfection cells were harvested for luciferase 
and CAT assay as previoulsly described (8), or used for proliferation and invasion assays. siRNA 
delivery and knockdown of COUP-TFII was obtained by TransIT-TKO Transfection Reagent 
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 8 
(Mirus Bio LLC, Medison WI) following the manufacturer's instructions. Specific and validate 
siRNA were purchased from QIAGEN (QIAGEN S.p.A, Milan Italy). Mycoplasm contamination of 
cell cultures were excluded by MycoProbe (Mycoplasm detection kit, R&D Systems Mineapolis, 
MN USA)   
 
Statistical Analysis 
 
Results are expressed as mean ± SD for three experiments done in triplicate or quadruplicate. Group 
means were compared by analysis of variance (ANOVA), followed by the Student-Newman-Keuls 
test if the former was significant. A P value < .05 was considered statistically significant.  
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Results 
 
COUP-TFII expression is increased in cirrhotic liver. 
In normal human liver COUP-TFII is expressed in the nucleus of non-parenchymal elements 
sparsely distributed in the sinusoids as well as in stromal cells of portal tracts (Fig. 1A). In cirrhotic 
livers the number of COUP-TFII expressing cells appears strikingly increased. Most of these cells 
are localized within the fibrotic septa and enlarged portal areas, although an increased expression in 
perisinusoidal cells in the liver lobule is also visible. COUP-TFII expressing cells are also positive 
for the mesenchymal cell marker vimentin and for the activated stellate-cells/myofibroblas marker 
alpha-smooth muscle actin (-SMA) (Fig. 1A inset, Supplementary Fig. S1A, S1C); on the contrary 
COUP-TFII expression does not colocalized with the macrophage marker CD68 (Supplementary 
Fig. 1B, 1D)  suggesting that COUP-TFII positive cells are activated HSC/myofibroblasts. 
We next sought to recapitulate these finding in the context of a mouse model of liver fibrosis by 
chronic administration of CCl4. Expression of COUP-TFII was sparsely distributed in the liver 
lobule of control mice (Supplementary Fig. S2A) whereas, in cirrhotic liver,  expression of this 
receptor was significantly increased in -SMA positive cells localized within fibrotic septa 
(Supplementary Fig. S2C, S2E). Although, the expression of GFAP, a marker of quiescent HSC, is 
strongly reduced in the parenchyma of the cirrhotic liver, COUP-TFII/GFAP double positive cells 
could be observed mainly in fibrotic septa, suggesting a progressive  expression of this receptor in 
the process of HSC activation (Supplementary Fig. S2D, S2F).   
 
COUP-TFII gene expression increases during HSC activation in vivo and in vitro  
To further validate this observation, COUP-TFII expression in liver injury was monitored in vivo 
after a single intraperitoneal injection of CCl4. In control mice, confocal microscopy analysis 
showed  that COUP-TFII expressing-cells distributed in the sinusoids are desmin-positive (Fig. 1B). 
Forty eight hours after CCl4 injection there is a significant increase in COUP-TFII positive cells, 
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particularly around portal areas where tissue damage is more pronounced. After 72 hours, the 
increase in COUP-TFII expression is paralleled by a marked increase of desmin and -SMA (Fig. 
1B), thus suggesting that COUP-TFII expressing cells may be HSC undergoing activation. 
Next, we characterized the expression profile of COUP-TFII during HSC transdifferentiation in 
vitro. Freshly-isolated human HSC do not express COUP-TFII mRNA and protein as shown by  
immunohistochemistry (Fig. 1B, lower row) and Western blot (Supplementary Fig. S3A and S3B). 
However, COUP-TFII expression gradually increases after 24 hours, peaking between 48 and 72 
hours from plating and remains  highly expressed throughout HSC activation [documented by loss 
of the Oil-Red O stained lipid inclusions (Fig. 1B, lower row) and by the increased of -SMA 
expression (Supplementary Fig. S3B)]. In contrast, COUP-TFI is weakly expressed in quiescent 
cells and its expression remains low at each time point (Supplementary Fig. S3A and S3B). COUP-
TFII transcriptional activity was further evaluated by transfection with a COUP-TFII reporter 
plasmid (NHE4-TK-LUC) (17). Reporter expression rapidly increased with the duration of culture 
reaching more than 10-fold increase between 48 and 72 hours after plating. Although at lower 
levels, COUP-TFII transcriptional activity remains significantly high after 72 hours of culture and 
during successive passages on plastic (Supplementary Fig. S3C).  
 
COUP-TF II regulates proliferation and invasiveness of activated HSC 
 
Considering that the expansion of HSC pool in injured liver is a fundamental feature of hepatic 
fibrosis and that COUP-TFII modulates genes involved in cell growth and motility (18),  we 
evaluated the role of COUP-TFII on HSC proliferation and invasiveness by gain and loss of 
function experiments using a dominant negative COUP-TFII (COUP-TFIIC134S) (Supplementary 
Fig.S4) or COUP-TFII silencing by siRNA. Transfection of wild type COUP-TFII (COUP-TFIIwt) 
induced a significant increase in DNA synthesis and cell growth (Fig. 2A, 2C). On the contrary, 
transfection of COUP-TFIIC134S reduced basal and serum-stimulated [
3
H]TdR incorporation and cell 
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number. Conversely, silencing of COUP-TFII prevented both basal and serum induced HSC 
proliferation, confirming the role of the nuclear receptor in the regulation of HSC growth. (Fig. 2B-
2D). COUP-TFII transcriptional activity was monitored by co-transfection with the NHE4-TK-Luc 
reporter in cells maintained in the same experimental conditions. Luciferase activity was induced by 
expression of COUP-TFIIwt  whereas it was inhibited by both COUP-TFIIC134S expression (Fig. 2E)  
and COUP-TFII silencing (Fig. 2F). The role of COUP-TFII on the ability of HSC invasiveness was 
assessed using Boyden chambers. COUP-TFIIwt overexpression induced a significant stimulation of 
HSC invasiveness, whereas transfection of COUP-TFIIC134S or COUP-TFII siRNA abrogated HSC 
invasiveness in presence or absence of transfected COUP-TFIIwt (Fig. 3A, 3B).     
 
COUP-TF II targets proinflammatory and proangiogenic genes in human HSC 
 
To identify novel transcription target genes of COUP-TFII that could account for the activated 
phenotype of human HSC, an exploratory microarray analysis was performed with mRNA extracted 
from cultured HSC transfected with COUP-TFIIwt or control plasmid. A functional analysis with 
gene ontology categories showed a significant enrichment of fibrogenic-related functions in COUP-
TFII overexpressing cells (i.e., response to wounding, immune response, motility, proliferation and 
angiogenesis) (Fig. 4 and Supplementary Table 1).  Validation of selected targets of interest 
obtained from microarray data was performed by RT-qPCR with mRNA extracted from COUP-
TFII-overexpressing and COUP-TFII-silenced HSC. This analysis confirmed that COUP-TFII 
regulates proangiogenic and proinflammatory genes such as cathepsin S, MMP-9, VEGF-C, IL-8, 
MCP-1, IP-10, ICAM-1 and ANGPTL4 (Supplementary Fig. S5). In addition, we showed that HSC 
profibrogenic markers, α-SMA and collagen 1α2 (Col1α2) were modulated by COUP-TFII 
expression (Supplementary Fig. 6). It is well known that the expression of inflammatory and 
angiogenic factors mainly relies on the balance between the activation of nuclear factor -B (NF-
B) and activator protein 1 (AP-1) and repression of PPAR transcriptional activity (19). Reporter 
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assay experiments showed that both NF-B and AP-1 were highly activated in COUP-TFII 
transfected HSC, whereas COUP-TFII overexpression completely abrogated ligand dependent and 
independent PPAR transcriptional activity (Suppplementary Fig. S7).  
 
 COUP-TFII deletion in HSC prevents inflammation and neo-angiogenesis in mice 
 
In order to assess the role of COUP-TFII during liver injury in vivo,  COUP-TFII
fl/fl 
-GFAP Cre
- 
and 
COUP-TFII
fl/fl 
-GFAP Cre
+ 
(Supplementary Fig. 8A) mice were treated with a single dose of CCl4. 
CCl4 metabolism and hepatocyte toxicity were not different between the two strains after 
intoxication as shown by ALT activity, MDA concentration and CYP2E1 levels (Supplementary 
Fig. 9). HSC freshly isolated from CCl4-treated COUP-TFII
fl/fl 
-GFAP Cre
+
 mice did not express 
COUP-TFII, on the contrary high COUP-TFII expression was documented in HSC isolated from  
COUP-TFII
fl/fl 
-GFAP Cre
- 
 at 72 hours after intoxication (Supplementary Fig. 8B, 8C).  Upon 
culture on plastic, HSC isolated from COUP-TFII
fl/fl
-GFAP Cre
-
 had high COUP-TFII 
transcriptional activity and underwent myofibroblastic transdifferentiation as demonstrated by 
increased expression of -SMA, progressive reduction of PPAR and a significant increase of cell 
proliferation (Fig. 5A-5C) . On the contrary, HSC from COUP-TFII
fl/fl 
-GFAP Cre
+ 
 maintained 
minimal -SMA expression and high level of PPAR after six day of culture (Fig. 5A).  
A significant reduction of -SMA expression was demonstrated in liver section from COUP-TFIIfl/fl 
-GFAP Cre
+
 compared with COUP-TFII
fl/fl
-GFAP Cre
-
 at 72 hours after CCl4 intoxication (Fig. 
5D). Furthermore,  COUP-TFII
fl/fl
-GFAP Cre
+
 mice showed a significant reduction of both the 
macrophage cell marker F4/80 and the endothelial cell marker CD31. These data were strengthened 
by RT-qPCR showing that the expression of -SMA are dependent on COUP-TFII presence in 
HSC isolated from COUP-TFII
fl/fl 
-GFAP Cre
- 
and COUP-TFII
fl/fl 
-GFAP Cre
+ 
mice (Fig. 5F). In 
addition, gene expression of proinflammatory and proangiogenic mediators were decreased in HSC 
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isolated from COUP-TFII
fl/fl 
-GFAP Cre
+ 
(Fig. 5F). Taken together these results confirm that 
COUP-TFII is involved in HSC regulation of inflammatory and angiogenic responses during liver 
injury. The proangiogenic role of COUP-TFII was also confirmed by the significant reduction of 
hepatic microcirculation in CCl4-treated COUP-TFII
fl/fl 
-GFAP Cre
+
mice (Supplementary Fig. 10). 
We next evaluated whether COUP-TFII deletion in HSC affect development of liver fibrosis after 
chronic treatment with CCl4 and in BDL mice. As shown in Figure 5E, Sirius red staining in the 
liver was significantly reduced in COUP-TFII
fl/fl 
-GFAP Cre
+
 mice compared with COUP-TFII
fl/fl 
-
GFAP Cre
-
 mice. Similarly, COUP-TFII deletion in HSC significantly affected cholestatic fibrosis 
(Fig. 5E). 
 
COUP-TFII expression in HSC promotes endothelial cells migration and tube formation in a 
hypoxia-independent manner. 
 
Liver sinusoidal endothelial cells (SEC) migration is a key step in liver angiogenesis especially in 
the cirrhotic microenvironment (20). In order to ascertain whether expression of COUP-TFII in 
HSC mediated hepatic angiogenesis, transfected HSC were co-cultured with SEC in a transwell 
system. Coculture with COUP-TFIIwt-overexpressing HSC significantly enhanced SEC 
chemiotaxis, whereas the presence of COUP-TFIIC134S-transfected HSC inhibited SEC migration 
(Fig. 6A). Furthermore, conditioned medium from COUP-TFIIwt-transfected HSC strongly induces 
SEC tubulogenesis, and this effect was abrogated by cotransfection with COUP-TFIIC134S (Fig. 6B). 
These data suggest that COUP-TFII might play a central role in the modulation of the angiogenic 
responses during liver fibrosis via an active cross-talk between SEC and HSC for sinusoidal 
remodelling.   
We next determined whether COUP-TFII contributes to the hypoxia-induced proangiogenic 
phenotype of HSC (21). COUP-TFII expression and transcriptional activity was not modulated in 
the presence of hypoxic conditions (Fig. 7A).  On the other hand,  COUP-TFII expression did not 
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affected either the expression of the both hypoxia-inducible factors HIF-1 and HIF-2 or their 
reporter activity in HSC (Fig. 7B). In addition, silencing of HIF-1 (ARNT), the constitutive 
binding partner of HIF- isoforms, abrogated hypoxia-induced HIF transcriptional activity both in 
presence and absence of transfected COUP-TFII (Fig. 7C), but did not influence either COUP-TFII 
expression or its transcriptional activity (Fig. 7D, 7E). Accordingly, tubulogenesis of SEC treated 
with the conditioned medium of COUP-TFII-overexpressing HSC was not affected by ARNT 
silencing independently of hypoxia conditions (Fig. 7F). These results indicate that COUP-TFII 
might contribute to liver angiogenesis in both normoxic and hypoxic conditions regardless of HIF 
activity.   
 
NF-kB regulates COUP-TFII-mediated angiogenic response in HSC 
 
Considering that NF-kB is involved in HIF-independent angiogenesis (22),  we tested whether NF-
kB activity is involved in the COUP-TFII-induced angiogenesis. To directly examine the 
involvement of NF-kB we silenced RELA, the p65 subunit of NF-kB, in COUP-TFII 
overexpressing HSC and examined the ability of the conditioned media of these cells to influence 
SEC angiogenesis. As reported in Fig. 8A, RELA silencing in HSC blocked SEC tubulogenesis 
induced by conditioned medium from COUP-TFII-overexpressing HSC. Furthermore,  to confirm 
the role of NF-kB in COUP-TFII proangiogenic function we evaluated the effect of RELA silencing 
on IL-8 and VEGF-C, two COUP-TFII-regulated gene that are known to preserve the angiogenic 
response independently of HIF pathway (24).   
A significant increase of IL-8 protein was measured in conditioned media of COUP-TFII-
overexpressing HSC (Fig. 8C and Supplementary Fig S11A). Media preincubation with a 
neutralizing antibody against IL-8 strongly attenuated LEC migration thus supporting the role of IL-
8 in the COUP-TFII-dependent proangiogenic crosstalk between SEC and HSC (Supplementary 
Fig. S11B). RELA silencing significantly impaired the COUP-TFII-induced stimulation of IL-8 
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steady state mRNA levels and protein synthesis in transfected HSC (Fig. 8B, 8C). Similarly RELA 
silencing inhibited COUP-TFII-induced expression of VEGF-C in HSC (Fig. 8D, 8E), confirming 
the dependence on NF-kB of the COUP-TFII-proangiogenic function.  In consideration that COUP-
TFII can function as positive accessory regulator for many different genes and activate transcription 
through protein-protein interaction with DNA-bound factors (11), we performed chromatin 
immunoprecipitation using COUP-TFII-expressing HSC. Antibodies raised against COUP-TFII 
could efficiently immunoprecipitate DNA fragments of IL-8 promoter corresponding two NF-kB 
response elements (Supplementary Fig. S11C).               
 
Notch signalling modulates COUP-TFII expression in HSC           
 
Notch pathway is the master regulator of COUP-TFII expression during vasculogenesis and Notch 
inhibition promotes angiogenesis causing pathogenic activation of liver stromal cells (13, 25).  We 
tested the effect of Notch activation on COUP-TFII in HSC. Soluble recombinant protein of Notch 
ligands Jag-1 and Dll4 were directly added in the culture media of HSC. Jag-1 but not Dll4 strongly 
repressed COUP-TFII expression and transcriptional activity (Supplementary Fig. S12A, S12B). 
We found that Hey-1, among many Notch downstream effectors tested was exclusively induced by 
Jag-1 (Supplementary Fig. S12C, S12D). Hey-1 silencing by siRNA induced COUP-TFII 
expression reversing Jag-1 mediated COUP-TFII down-regulation (Supplementary Fig. S12E). 
Finally, we demonstrated that increased COUP-TFII expression by transfection selectively 
modulated Hes-1 and Hey1 expression (Supplementary Fig S12F).  
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Discussion 
 
The activation of HSC has been proposed as a key event in chronic liver diseases and these cells are 
currently considered the crossroads of fibrosis, inflammatory response, and angiogenesis during 
hepatic wound healing (3). The results of the current study indicate that the nuclear receptor COUP-
TFII plays a paramount role in the HSC acquisition of proangiogenic phenotype and in the 
orchestration of myofibroblast-endothelial interaction during liver injury. COUP-TFII is highly 
expressed in human and rodent cirrhotic liver, in particular in -SMA positive HSC/myofibroblasts. 
COUP-TFII is rapidly up regulated in HSC upon activation and its inhibition leads to the inhibition 
of HSC transdifferentiation delaying the PPAR down-regulation and the acquisition of 
myofibroblast markers. It has been recently reported that COUP-TFII is a negative regulator in 
adipogenesis and that ectopic expression of COUP-TFII in preadipocytes blocks fat-storing and 
prevents the induction of adipogenic transcription factors such as PPAR and LXR (24). 
Furthermore, COUP-TFII has been shown to be a direct target of Wnt/-catenin signalling pathway 
in preadipocytes and HSC and it mediates chromatin hypoacetylation and the consequent PPAR 
repression (16, 9). Based on this background and on the results of the present study it is possible to 
speculate that COUP-TFII plays a primary role in early HSC activation via a Wnt-dependent control 
of PPAR repression. In addition, COUP-TFII is a downstream target of Hedgehog and Notch 
pathways (26), that were shown to control the HSC phenotype by regulating metabolism and 
inflammatory response (27, 28). Accordingly, it is conceivable to propose that COUP-TFII acts as a 
gatekeeper in promoting HSC transdifferentiation and that the cross-regulation between COUP-TFII 
and PPAR provides the molecular basis underlying the remarkable cell plasticity of HSC.   
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COUP-TFII expression in HSC modulates an array of genes involved in different aspects of the 
wound healing process. In particular, COUP-TFII controls the expression of a wide range of 
chemokines that function in specific autocrine and paracrine axes to coordinate cellular interactions 
and promote migration and proliferation of immune and angiogenic cells (29). Livers from mice 
with COUP-TFII deletion in HSC show a concomitant reduced expression of mesenchymal and 
endothelial markers in association with a significant inhibition of HSC expression of 
proinflammatory and proangiogenic mediators. Furthermore, inhibition of COUP-TFII blunts HSC 
proliferation and invasiveness. Interestingly, cancer cells invasiveness is associated with COUP-
TFII expression and up-regulation of gelatinolitic and fibrinolitic activity (30-31). Similarly, 
COUP-TFII expression in HSC positively regulates uPA and MMP-9 which play e central role in 
hepatic wound healing (32).   
 
The most intriguing function of COUP-TFII emerging from the results of the present study is its 
role in sinusoidal remodelling and neoangiogenesis. Neoangiogenesis and the establishment of an 
abnormal angioarchitecture are typical of  the pathological progression of chronic liver disease to 
cirrhosis (21). Interestingly, we showed that COUP-TFII regulates the HSC/SEC cross-talk that is 
considered of primary importance not just in fibrogenesis but also in liver regeneration and tumor 
angiogenesis (33).  In a co-culture system COUP-TFII-overexpressing HSC release potent 
angiogenic molecules and promote SEC migration and tubulogenesis. Accordingly, accumulating 
evidence support the importance of COUP-TFII in angiogenic pathways. COUP-TFII is necessary 
during normal developmental angiogenesis and lymphoangiogensis, as evinced by the impaired 
vessel formation and embryonic lethality in COUP-TFII knockout mice (34). Quin et al. have also 
demonstrated that COUP-TFII is essential for cancer angiogenesis through regulation of pericyte-
derived paracrine signals that target endothelium (14). Furthermore, COUP-TFII regulates tumor 
lymphoangiogenesis by expression of VEGF-C (31) that is one of the main angiogenic factors 
produced by COUP-TFII-expressing HSC and it recognizes VEGFR-2 and VEGFR-3 receptors that 
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are expressed in SEC (35). In consideration that angiogenic and antiadipogenic pathways converge 
in different animal models of chronic metabolic diseases (36), we drew the hypothesis that COUP-
TFII functions as a transcriptional hub integrating different inputs to establish a specific reparative 
niche where the paracrine interplay between HSC and SEC regulates the wound healing process.  
 
The transcriptional mechanisms by which COUP-TFII regulates angiogenic response in the liver are 
peculiar. Indeed it is well established that hepatic neoangiogenesis induced by hypoxia is a common 
feature of fibrosis and occurs through activation of HIF transcription factors (21, 37).  However, the 
results of the present study  demonstrated that COUP-TFII expression and transcriptional activity is 
completely independent on hypoxia. In addition, inactivation of COUP-TFII has no effect on HIF 
isoforms expression and transcriptional activity. Thus, these findings allow to introduce the new 
concept that modulation of angiogenic factors and neovascularization during liver injury may 
involve hypoxia- and HIF-1-independent mechanisms.  In colon cancer, xenografts knockout of 
HIF-1 does not block angiogenesis and a NF-kB-dependent expression of IL-8 and angiogenin is 
involved in hypoxia-independent angiogenesis (22).  Here we demonstrated that COUP-TFII 
positively controls NF-kB transcriptional activity in HSC and that NF-kB silencing abrogates 
COUP-TFII-regulated expression of IL-8 and VEGF-C, interrupting the pro-angiogenic cross-
interaction between HSC and SEC. Although HIF and NF-kB have a significant and profound 
crosstalk, it has recently became apparent that they act independently in response of angiocrine non-
hypoxic stimuli such as bacterial LPS, TNF, and reactive oxygen species (38). Both hypoxia/HIF-
dependent and COUP-TFII (hypoxia/HIF-independent)-mediated pathways can influence NF-kB, 
but it remains to be seen in which context one function can prevail over the other during the 
progression of chronic liver injury.  It is possible that these pathways cooperate to provide 
redundant signals for NF-kB activation in promoting sinusoidal remodelling. Alternatively, in 
consideration that COUP-TFII-dependent angiogenesis is tightly coupled to HSC activation, we can 
presume that this pathway may be predominant in the early phase of healing response in non 
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hypoxic regions and promote the early recruitment of SEC that are required for liver regeneration 
(35, 39). Finally, we demonstrated that Notch pathway that has a central role during angiogenesis 
and inflammation by repressing NF-kB (28, 40),  is an important mediator of COUP-TFII 
expression in HSC, confirming the complex network involved in the regulation of NF-kB activity.  
Further studies will be necessary to elucidate the molecular mechanisms involved in the COUP-
TFII regulation of NF-kB transcriptional activity and whether COUP-TFII/NF-kB interactions are 
important for the perpetuation and resolution of liver fibrosis. 
In conclusion, our study uncovers COUP-TFII as a critical new leading player in hepatic wound 
healing process controlling multiple profibrogenic pathways. The evidence that COUP-TFII 
deletion has a little impact in adult physiological functions and that its transcriptional activity could 
be potentially regulated by ligands (11, 41), indicate this nuclear receptor a promising target for 
antifibrotic interventions and stimulate future investigations to identify COUP-TFII specific 
antagonists to be tested for the therapy of chronic liver diseases.  
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Figure Legends 
 
Figure 1:  COUP-TFII expression during liver injury and HSC activation. 
(A) COUP-TFII in normal (lower row) and cirrhotic (upper row) human liver. First and second 
column shown immunohistochemistry of COUP-TFII (DAB, brown colour). Original magnification  
50x and 200x respectively. Counterstain: methyl green. Third column shows double-
immunohistochemistry of COUP-TFII (DAB, brown) and α-SMA (AP Magenta, red). Inset original 
magnification 200x. Fourth column shows confocal microscopy double-immunofluorescence of 
COUP-TFII (green) and vimentin (red) expression. Scale bar 50m. (B). Confocal microscopy 
double-immunoflurescence of COUP-TFII (red) and α-SMA (green) (upper row) and COUP-TFII 
(red) and Desmin (green) (middle row) in a mouse model of acute liver damage by CCl4 injection. 
Scale bar 50 µm. Third row shows immunocytochemistry of COUP-TFII (DAB, black) expression 
during plastic-induced activation of HSC. Counter stain: Oil Red O. Original magnification 400x. 
 
Figure 2. COUP-TFII is involved in HSC proliferation and invasiveness. Quiescent human 
HSC were transfected with COUP-TFII expression plasmids or with specific siRNA. Twenty four 
hours after transfection culture medium was replaced with fresh medium with or without 10% FBS 
and cells were cultured for a further 24 hours.  DNA synthesis and cell growth were evaluated by 
[3H]TdR  incorporation (A, B) and cell counting (C, D) respectively. Western Blots panels show 
COUP-TFII expression in transfected HSC, β2-microglobulin (β2-M) was used as loading control. 
(E-F) Quiescent human HSC were cotransfected with NHE4-TK-LUC reporter,  pSV2CAT and 
COUP-TFII expression plasmids as indicated. Twenty four hours after transfection fresh medium 
was replace with or without 10% FBS. After 24 hours of incubation cells were harvested for 
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luciferase and CAT activity. B) COUP-TFII specific siRNA or control siRNA (siControl) were 
delivered in NHE4-TK-LUC transfected cells. Data are represented as average ± SD,   * P<0.05 or 
higher degree of significance versus empty vector or control siRNA transfected cells in presence or 
absence of FBS respectively. 
 
Figure 3. Quiescent human HSC were transfected with COUP-TFII expression plasmids (A) or 
with specific siRNA (B). Forty eight hours after transfection cells were trypsinized and used for the 
invasion assay. Lower panels: original magnification 100X. Data are represented as average ± SD, 
*P<0.05 or higher degree of significance versus empty vector or control siRNA transfected cells. 
**P< 0.04 versus COUP-TFIIwt transfected cells.      
 
 
Figure 4. COUP-TFII targets proinflammatory and proangiogenic genes in human HSC. Heat 
map of microarray analysis in COUP-TFII transfected HSC. Gene Ontology (GO) over-
representation analysis was performed with the Biological Network Gene Ontology (BINGO) plug-
in for the Cytoscape visualization software.  
 
Figure 5. Impact of COUP-TFII deletion in HSC after CCl4 treatment. (A) Levels of -SMA, 
PPAR and COUP-TFII in HSC freshly isolated from transgenic mice. (B) [3H]TdR incorporation 
was monitored at the different time points. Data are represented as average ± SD, * P< 0.01 versus 
HSC from COUP-TFII-GFAP Cre
+
 mice. (C) COUP-TFII transcriptional activity was monitored in 
HSC isolated from transgenic mice and cultured on plastic. Cells were transfected with the NHE4-
TK-LUC reporter and  pSV2CAT as an internal control for transfection efficiency at different time 
points. Data are represented as average ± SD, * P< 0.01 versus HSC from COUP-TFII-GFAP Cre
+
 
mice. (D) Confocal images showing immunostaining for -SMA, CD31 and F4/80. Scale bar 20 
µm. Graphs on the right represent a percentage of area occupied by the signal measured by video-
image analysis. For each sample a total of 5 non-consecutive hepatic sections were measured. Data 
are represented as average ± SD, * P< 0.05 or higher degree of significance versus COUP-TFII-
GFAP Cre
-
 mice. (E) Sirius red staining in liver section from COUP-TFII-GFAP Cre
+
 and COUP-
TFII-GFAP Cre
-
 mice treated with CCl4 for 4 weeks or after bile duct ligation. (F) Seventy two 
hours after CCl4 injection HSC were isolated from transgenic mice. Total RNA was extracted and 
RT-PCR was performed with specific primers. Data are from three independent experiments and 
indicated as average ± SD. * P <  0.05 or higher degree of significance versus control.  
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Figure 6. COUP-TFII expression in HSC regulates proangiogenic crosstalk with SEC. (A) 
SEC migration was measured using transwell coculture system. Transwell filters with adherent SEC 
monolayer were applied on transfected HSC culture 72 hours after transfection. Data are 
represented as average ± SD, * P<0.05 or higher degree of significance versus empty vector 
transfected cells. ** P< 0.03 versus COUP-TFIIwt transfected cells. (B) SEC tubulogenesis was 
evaluated after 6 hours incubation in conditioned media obtained from transfected HSC. Data are 
represented as average ± SD, ** P< 0.02 versus COUP-TFIIwt cells.  
 
Figure 7. COUP-TFII expression in HSC regulates angiogenesis with a hypoxia and HIF 
independent manner. (A) Twenty four hours after transfection with NHE4-TK-Luc reporter,  HSC 
were incubated in strictly controlled hypoxic condition for 24 hours and then harvested for 
luciferase and CAT activity. Inset shows COUP-TFII expression in cultured HSC after 24 hours 
incubation in hypoxic conditions. (B) HSC were co-transfected with HIF-TK-Luc reporter, COUP-
TFIIwt or COUP-TFIIC134S and then incubated in normoxia or hypoxia condition (3% O2 ). Insect 
shows HIF isoforms expression in COUP-TFIIwt and COUP-TFIIC134S  transfected HSC. (C) 
Inhibition of HIF transcriptional activity in COUP-TFIIwt or empty vector transfected HSC was 
obtained by silencing ARNT. Data are represented as average ± SD, * P <  0.05 or higher degree of 
significance versus empty vector transfected cells or versus siCon transfected cells. (D) ARNT 
silencing does not modulate NHE4-TK-Luc reporter activity. * P<0.01 versus empty vector 
transfected cells. (E) Western Blot shows ARNT silencing in COUP-TFIIwt transfected HSC. (F) 
Culture medium of transfected HSC exposed to hypoxia (3% O2 ) for 24 hours was collected and 
use for SEC tube formation assay.  Data are represented as average ± SD, * P<0.01 versus empty 
vector/siCon transfected cells. 
 
Figure 8. NF-kB is involved in COUP-TFII regulation of proangiogenic response. Inhibition of 
NF-kB in transfected HSC was obtained by silencing RELA. (A) SEC tubulogenesis was evaluated 
after 6 hours incubation in conditioned media obtained from transfected HSC. * P<0.02 versus 
empty vector/siCon transfected cells. Data are represented as average ± SD, ** P< 0.05 versus 
COUP-TFIIwt/siCon transfected cells. (B, D) Twenty four hours after transfection total RNA was 
extracted from transfected HSC and RT-PCR was performed. Data are represented as average ± SD 
*P <  0.01 versus empty vector/siCon transfected cells, ** P < 0.03 versus COUP-TFII transfected 
cells or higher degree of significance.  (C and F) De novo synthesis of IL-8 and VEGF-C were 
determined in HSC supernatants by ELISA. Data are represented as average ± SD, * P <  0.01 
versus empty vector/siCon transfected cells, ** P< 0.05 versus COUP-TFII/siCon transfected cells.  
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